Global Budesonide Sales Market Report 2023

Publisher Name :
Date: 02-Jan-2023
No. of pages: 126
Inquire Before Buying

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Market Analysis and Insights: Global Budesonide Market

Due to the COVID-19 pandemic, the global Budesonide market size is estimated to be worth US$ 8203 million in 2022 and is forecast to a readjusted size of US$ 10250 million by 2029 with a CAGR of 3.2% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Injectable Suspension accounting for % of the Budesonide global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Respiratory Disease Treatment segment is altered to an % CAGR throughout this forecast period.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Global Budesonide Scope and Market Size

The global Budesonide market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.

Segment by Type

- Injectable Suspension

- Aerosols

- Inhalation Powder

- Tablet and Capsule

Segment by Application

- Respiratory Disease Treatment

- Nose Disease Treatment

- Inflammatory Bowel Disease Treatment

- Others

By Region

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Other Regions

By Company

- AstraZeneca

- Teva

- Mylan

- Sandoz

- Cosmo Pharmaceuticals

- Salix

- Chiesi Farmaceutici

- Orion Corporation

- Cipla

- Synmosa Biopharma

- Lunan Better Pharma

- Shanghai Sine Promod

Global Budesonide Sales Market Report 2023

Table of Contents
1 Budesonide Market Overview
1.1 Budesonide Product Scope
1.2 Budesonide Segment by Type
1.2.1 Global Budesonide Sales by Type (2018 & 2022 & 2029)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide Segment by Application
1.3.1 Global Budesonide Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Budesonide Market Estimates and Forecasts (2018-2029)
1.4.1 Global Budesonide Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Budesonide Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Budesonide Price Trends (2018-2029)
2 Budesonide Estimates and Forecasts by Region
2.1 Global Budesonide Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Budesonide Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Budesonide Sales Market Share by Region (2018-2023)
2.2.2 Global Budesonide Revenue Market Share by Region (2018-2023)
2.3 Global Budesonide Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Budesonide Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Budesonide Estimates and Projections (2018-2029)
2.4.2 Europe Budesonide Estimates and Projections (2018-2029)
2.4.3 China Budesonide Estimates and Projections (2018-2029)
2.4.4 Japan Budesonide Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Budesonide Estimates and Projections (2018-2029)
2.4.6 India Budesonide Estimates and Projections (2018-2029)
3 Global Budesonide Competition Landscape by Players
3.1 Global Top Budesonide Players by Sales (2018-2023)
3.2 Global Top Budesonide Players by Revenue (2018-2023)
3.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Budesonide as of 2022)
3.4 Global Budesonide Average Price by Company (2018-2023)
3.5 Manufacturers Budesonide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Budesonide Market Size by Type
4.1 Global Budesonide Historic Market Review by Type (2018-2023)
4.1.1 Global Budesonide Sales by Type (2018-2023)
4.1.2 Global Budesonide Revenue by Type (2018-2023)
4.1.3 Global Budesonide Price by Type (2018-2023)
4.2 Global Budesonide Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Budesonide Sales Forecast by Type (2024-2029)
4.2.2 Global Budesonide Revenue Forecast by Type (2024-2029)
4.2.3 Global Budesonide Price Forecast by Type (2024-2029)
5 Global Budesonide Market Size by Application
5.1 Global Budesonide Historic Market Review by Application (2018-2023)
5.1.1 Global Budesonide Sales by Application (2018-2023)
5.1.2 Global Budesonide Revenue by Application (2018-2023)
5.1.3 Global Budesonide Price by Application (2018-2023)
5.2 Global Budesonide Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Budesonide Sales Forecast by Application (2024-2029)
5.2.2 Global Budesonide Revenue Forecast by Application (2024-2029)
5.2.3 Global Budesonide Price Forecast by Application (2024-2029)
6 United States Budesonide Market Facts & Figures
6.1 United States Budesonide Sales by Company
6.1.1 United States Budesonide Sales by Company (2018-2023)
6.1.2 United States Budesonide Revenue by Company (2018-2023)
6.2 United States Budesonide Sales Breakdown by Type
6.2.1 United States Budesonide Sales Breakdown by Type (2018-2023)
6.2.2 United States Budesonide Sales Breakdown by Type (2024-2029)
6.3 United States Budesonide Sales Breakdown by Application
6.3.1 United States Budesonide Sales Breakdown by Application (2018-2023)
6.3.2 United States Budesonide Sales Breakdown by Application (2024-2029)
7 Europe Budesonide Market Facts & Figures
7.1 Europe Budesonide Sales by Company
7.1.1 Europe Budesonide Sales by Company (2018-2023)
7.1.2 Europe Budesonide Revenue by Company (2018-2023)
7.2 Europe Budesonide Sales Breakdown by Type
7.2.1 Europe Budesonide Sales Breakdown by Type (2018-2023)
7.2.2 Europe Budesonide Sales Breakdown by Type (2024-2029)
7.3 Europe Budesonide Sales Breakdown by Application
7.3.1 Europe Budesonide Sales Breakdown by Application (2018-2023)
7.3.2 Europe Budesonide Sales Breakdown by Application (2024-2029)
8 China Budesonide Market Facts & Figures
8.1 China Budesonide Sales by Company
8.1.1 China Budesonide Sales by Company (2018-2023)
8.1.2 China Budesonide Revenue by Company (2018-2023)
8.2 China Budesonide Sales Breakdown by Type
8.2.1 China Budesonide Sales Breakdown by Type (2018-2023)
8.2.2 China Budesonide Sales Breakdown by Type (2024-2029)
8.3 China Budesonide Sales Breakdown by Application
8.3.1 China Budesonide Sales Breakdown by Application (2018-2023)
8.3.2 China Budesonide Sales Breakdown by Application (2024-2029)
9 Japan Budesonide Market Facts & Figures
9.1 Japan Budesonide Sales by Company
9.1.1 Japan Budesonide Sales by Company (2018-2023)
9.1.2 Japan Budesonide Revenue by Company (2018-2023)
9.2 Japan Budesonide Sales Breakdown by Type
9.2.1 Japan Budesonide Sales Breakdown by Type (2018-2023)
9.2.2 Japan Budesonide Sales Breakdown by Type (2024-2029)
9.3 Japan Budesonide Sales Breakdown by Application
9.3.1 Japan Budesonide Sales Breakdown by Application (2018-2023)
9.3.2 Japan Budesonide Sales Breakdown by Application (2024-2029)
10 Southeast Asia Budesonide Market Facts & Figures
10.1 Southeast Asia Budesonide Sales by Company
10.1.1 Southeast Asia Budesonide Sales by Company (2018-2023)
10.1.2 Southeast Asia Budesonide Revenue by Company (2018-2023)
10.2 Southeast Asia Budesonide Sales Breakdown by Type
10.2.1 Southeast Asia Budesonide Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Budesonide Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Budesonide Sales Breakdown by Application
10.3.1 Southeast Asia Budesonide Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Budesonide Sales Breakdown by Application (2024-2029)
11 India Budesonide Market Facts & Figures
11.1 India Budesonide Sales by Company
11.1.1 India Budesonide Sales by Company (2018-2023)
11.1.2 India Budesonide Revenue by Company (2018-2023)
11.2 India Budesonide Sales Breakdown by Type
11.2.1 India Budesonide Sales Breakdown by Type (2018-2023)
11.2.2 India Budesonide Sales Breakdown by Type (2024-2029)
11.3 India Budesonide Sales Breakdown by Application
11.3.1 India Budesonide Sales Breakdown by Application (2018-2023)
11.3.2 India Budesonide Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Budesonide Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.1.4 AstraZeneca Budesonide Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Teva Budesonide Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Mylan Budesonide Products Offered
12.3.5 Mylan Recent Development
12.4 Sandoz
12.4.1 Sandoz Corporation Information
12.4.2 Sandoz Business Overview
12.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Sandoz Budesonide Products Offered
12.4.5 Sandoz Recent Development
12.5 Cosmo Pharmaceuticals
12.5.1 Cosmo Pharmaceuticals Corporation Information
12.5.2 Cosmo Pharmaceuticals Business Overview
12.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Cosmo Pharmaceuticals Budesonide Products Offered
12.5.5 Cosmo Pharmaceuticals Recent Development
12.6 Salix
12.6.1 Salix Corporation Information
12.6.2 Salix Business Overview
12.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Salix Budesonide Products Offered
12.6.5 Salix Recent Development
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Corporation Information
12.7.2 Chiesi Farmaceutici Business Overview
12.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Chiesi Farmaceutici Budesonide Products Offered
12.7.5 Chiesi Farmaceutici Recent Development
12.8 Orion Corporation
12.8.1 Orion Corporation Corporation Information
12.8.2 Orion Corporation Business Overview
12.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Orion Corporation Budesonide Products Offered
12.8.5 Orion Corporation Recent Development
12.9 Cipla
12.9.1 Cipla Corporation Information
12.9.2 Cipla Business Overview
12.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Cipla Budesonide Products Offered
12.9.5 Cipla Recent Development
12.10 Synmosa Biopharma
12.10.1 Synmosa Biopharma Corporation Information
12.10.2 Synmosa Biopharma Business Overview
12.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Synmosa Biopharma Budesonide Products Offered
12.10.5 Synmosa Biopharma Recent Development
12.11 Lunan Better Pharma
12.11.1 Lunan Better Pharma Corporation Information
12.11.2 Lunan Better Pharma Business Overview
12.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Lunan Better Pharma Budesonide Products Offered
12.11.5 Lunan Better Pharma Recent Development
12.12 Shanghai Sine Promod
12.12.1 Shanghai Sine Promod Corporation Information
12.12.2 Shanghai Sine Promod Business Overview
12.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Shanghai Sine Promod Budesonide Products Offered
12.12.5 Shanghai Sine Promod Recent Development
13 Budesonide Manufacturing Cost Analysis
13.1 Budesonide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Budesonide
13.4 Budesonide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Budesonide Distributors List
14.3 Budesonide Customers
15 Market Dynamics
15.1 Budesonide Industry Trends
15.2 Budesonide Market Drivers
15.3 Budesonide Market Challenges
15.4 Budesonide Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Budesonide Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Budesonide Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
Table 3. Global Budesonide Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Budesonide Sales (M Units) by Region (2018-2023)
Table 5. Global Budesonide Sales Market Share by Region (2018-2023)
Table 6. Global Budesonide Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Budesonide Revenue Share by Region (2018-2023)
Table 8. Global Budesonide Sales (M Units) Forecast by Region (2024-2029)
Table 9. Global Budesonide Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Budesonide Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Budesonide Revenue Share Forecast by Region (2024-2029)
Table 12. Global Budesonide Sales by Company (M Units) & (2018-2023)
Table 13. Global Budesonide Sales Share by Company (2018-2023)
Table 14. Global Budesonide Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Budesonide Revenue Share by Company (2018-2023)
Table 16. Global Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2022)
Table 17. Global Market Budesonide Average Price by Company (USD/K Units) & (2018-2023)
Table 18. Manufacturers Budesonide Manufacturing Sites and Area Served
Table 19. Manufacturers Budesonide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Budesonide Sales by Type (2018-2023) & (M Units)
Table 22. Global Budesonide Sales Share by Type (2018-2023)
Table 23. Global Budesonide Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Budesonide Price by Type (2018-2023) & (USD/K Units)
Table 25. Global Budesonide Sales by Type (2024-2029)
Table 26. Global Budesonide Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Budesonide Revenue Share by Type (2024-2029)
Table 28. Global Budesonide Price by Type (2024-2029) & (USD/K Units)
Table 29. Global Budesonide Sales by Application (2018-2023) & (M Units)
Table 30. Global Budesonide Sales Share by Application (2018-2023)
Table 31. Global Budesonide Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Budesonide Price by Application (2018-2023) & (USD/K Units)
Table 33. Global Budesonide Sales by Application (2024-2029) & (M Units)
Table 34. Global Budesonide Sales Share by Application (2024-2029)
Table 35. Global Budesonide Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Budesonide Revenue Share by Application (2024-2029)
Table 37. Global Budesonide Price by Application (2024-2029) & (USD/K Units)
Table 38. United States Budesonide Sales by Company (2018-2023) & (M Units)
Table 39. United States Budesonide Sales Market Share by Company (2018-2023)
Table 40. United States Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Budesonide Revenue Market Share by Company (2018-2023)
Table 42. United States Budesonide Sales by Type (2018-2023) & (M Units)
Table 43. United States Budesonide Sales Market Share by Type (2018-2023)
Table 44. United States Budesonide Sales by Type (2024-2029) & (M Units)
Table 45. United States Budesonide Sales Market Share by Type (2024-2029)
Table 46. United States Budesonide Sales by Application (2018-2023) & (M Units)
Table 47. United States Budesonide Sales Market Share by Application (2018-2023)
Table 48. United States Budesonide Sales by Application (2024-2029) & (M Units)
Table 49. United States Budesonide Sales Market Share by Application (2024-2029)
Table 50. Europe Budesonide Sales by Company (2018-2023) & (M Units)
Table 51. Europe Budesonide Sales Market Share by Company (2018-2023)
Table 52. Europe Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Budesonide Revenue Market Share by Company (2018-2023)
Table 54. Europe Budesonide Sales by Type (2018-2023) & (M Units)
Table 55. Europe Budesonide Sales Market Share by Type (2018-2023)
Table 56. Europe Budesonide Sales by Type (2024-2029) & (M Units)
Table 57. Europe Budesonide Sales Market Share by Type (2024-2029)
Table 58. Europe Budesonide Sales by Application (2018-2023) & (M Units)
Table 59. Europe Budesonide Sales Market Share by Application (2018-2023)
Table 60. Europe Budesonide Sales by Application (2024-2029) & (M Units)
Table 61. Europe Budesonide Sales Market Share by Application (2024-2029)
Table 62. China Budesonide Sales by Company (2018-2023) & (M Units)
Table 63. China Budesonide Sales Market Share by Company (2018-2023)
Table 64. China Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Budesonide Revenue Market Share by Company (2018-2023)
Table 66. China Budesonide Sales by Type (2018-2023) & (M Units)
Table 67. China Budesonide Sales Market Share by Type (2018-2023)
Table 68. China Budesonide Sales by Type (2024-2029) & (M Units)
Table 69. China Budesonide Sales Market Share by Type (2024-2029)
Table 70. China Budesonide Sales by Application (2018-2023) & (M Units)
Table 71. China Budesonide Sales Market Share by Application (2018-2023)
Table 72. China Budesonide Sales by Application (2024-2029) & (M Units)
Table 73. China Budesonide Sales Market Share by Application (2024-2029)
Table 74. Japan Budesonide Sales by Company (2018-2023) & (M Units)
Table 75. Japan Budesonide Sales Market Share by Company (2018-2023)
Table 76. Japan Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Budesonide Revenue Market Share by Company (2018-2023)
Table 78. Japan Budesonide Sales by Type (2018-2023) & (M Units)
Table 79. Japan Budesonide Sales Market Share by Type (2018-2023)
Table 80. Japan Budesonide Sales by Type (2024-2029) & (M Units)
Table 81. Japan Budesonide Sales Market Share by Type (2024-2029)
Table 82. Japan Budesonide Sales by Application (2018-2023) & (M Units)
Table 83. Japan Budesonide Sales Market Share by Application (2018-2023)
Table 84. Japan Budesonide Sales by Application (2024-2029) & (M Units)
Table 85. Japan Budesonide Sales Market Share by Application (2024-2029)
Table 86. Southeast Asia Budesonide Sales by Company (2018-2023) & (M Units)
Table 87. Southeast Asia Budesonide Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Budesonide Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Budesonide Sales by Type (2018-2023) & (M Units)
Table 91. Southeast Asia Budesonide Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Budesonide Sales by Type (2024-2029) & (M Units)
Table 93. Southeast Asia Budesonide Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Budesonide Sales by Application (2018-2023) & (M Units)
Table 95. Southeast Asia Budesonide Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Budesonide Sales by Application (2024-2029) & (M Units)
Table 97. Southeast Asia Budesonide Sales Market Share by Application (2024-2029)
Table 98. India Budesonide Sales by Company (2018-2023) & (M Units)
Table 99. India Budesonide Sales Market Share by Company (2018-2023)
Table 100. India Budesonide Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Budesonide Revenue Market Share by Company (2018-2023)
Table 102. India Budesonide Sales by Type (2018-2023) & (M Units)
Table 103. India Budesonide Sales Market Share by Type (2018-2023)
Table 104. India Budesonide Sales by Type (2024-2029) & (M Units)
Table 105. India Budesonide Sales Market Share by Type (2024-2029)
Table 106. India Budesonide Sales by Application (2018-2023) & (M Units)
Table 107. India Budesonide Sales Market Share by Application (2018-2023)
Table 108. India Budesonide Sales by Application (2024-2029) & (M Units)
Table 109. India Budesonide Sales Market Share by Application (2024-2029)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 113. AstraZeneca Budesonide Product
Table 114. AstraZeneca Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 118. Teva Budesonide Product
Table 119. Teva Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 123. Mylan Budesonide Product
Table 124. Mylan Recent Development
Table 125. Sandoz Corporation Information
Table 126. Sandoz Description and Business Overview
Table 127. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 128. Sandoz Budesonide Product
Table 129. Sandoz Recent Development
Table 130. Cosmo Pharmaceuticals Corporation Information
Table 131. Cosmo Pharmaceuticals Description and Business Overview
Table 132. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 133. Cosmo Pharmaceuticals Budesonide Product
Table 134. Cosmo Pharmaceuticals Recent Development
Table 135. Salix Corporation Information
Table 136. Salix Description and Business Overview
Table 137. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 138. Salix Budesonide Product
Table 139. Salix Recent Development
Table 140. Chiesi Farmaceutici Corporation Information
Table 141. Chiesi Farmaceutici Description and Business Overview
Table 142. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 143. Chiesi Farmaceutici Budesonide Product
Table 144. Chiesi Farmaceutici Recent Development
Table 145. Orion Corporation Corporation Information
Table 146. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 147. Orion Corporation Description and Business Overview
Table 148. Orion Corporation Budesonide Product
Table 149. Orion Corporation Recent Development
Table 150. Cipla Corporation Information
Table 151. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 152. Cipla Description and Business Overview
Table 153. Cipla Budesonide Product
Table 154. Cipla Recent Development
Table 155. Synmosa Biopharma Corporation Information
Table 156. Synmosa Biopharma Description and Business Overview
Table 157. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 158. Synmosa Biopharma Budesonide Product
Table 159. Synmosa Biopharma Recent Development
Table 160. Lunan Better Pharma Corporation Information
Table 161. Lunan Better Pharma Description and Business Overview
Table 162. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 163. Lunan Better Pharma Budesonide Product
Table 164. Lunan Better Pharma Recent Development
Table 165. Shanghai Sine Promod Corporation Information
Table 166. Shanghai Sine Promod Description and Business Overview
Table 167. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 168. Shanghai Sine Promod Budesonide Product
Table 169. Shanghai Sine Promod Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Budesonide Distributors List
Table 173. Budesonide Customers List
Table 174. Budesonide Market Trends
Table 175. Budesonide Market Drivers
Table 176. Budesonide Market Challenges
Table 177. Budesonide Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales (US$ Million) by Type (2018 & 2022 & 2029)
Figure 3. Global Budesonide Sales Market Share by Type in 2022 & 2029
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Sales (US$ Million) by Application (2018 & 2022 & 2029)
Figure 9. Global Budesonide Sales Market Share by Application in 2022 & 2029
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Budesonide Sales Growth Rate (2018-2029) & (US$ Million)
Figure 16. Global Budesonide Sales (M Units) Growth Rate (2018-2029)
Figure 17. Global Budesonide Price Trends Growth Rate (2018-2029) & (USD/K Units)
Figure 18. Global Market Budesonide Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 19. Global Budesonide Revenue Market Share by Region: 2018 VS 2022
Figure 20. United States Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 21. United States Budesonide Sales (M Units) Growth Rate (2018-2029)
Figure 22. Europe Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 23. Europe Budesonide Sales (US$ Million) Growth Rate (2018-2029)
Figure 24. China Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 25. China Budesonide Sales (US$ Million) and Growth Rate (2018-2029)
Figure 26. Japan Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 27. Japan Budesonide Sales (US$ Million) Growth Rate (2018-2029)
Figure 28. Southeast Asia Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 29. Southeast Asia Budesonide Sales (US$ Million) Growth Rate (2018-2029)
Figure 30. India Budesonide Revenue (US$ Million) Growth Rate (2018-2029)
Figure 31. India Budesonide Sales (US$ Million) Growth Rate (2018-2029)
Figure 32. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide: 2018 & 2022
Figure 33. Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Budesonide Revenue Share by Type (2018-2023)
Figure 35. Global Budesonide Sales Share by Type (2024-2029)
Figure 36. Global Budesonide Revenue Share by Type (2024-2029)
Figure 37. Global Budesonide Revenue Share by Application (2018-2023)
Figure 38. Global Budesonide Revenue Growth Rate by Application in 2018 & 2022
Figure 39. Global Budesonide Sales Share by Application (2024-2029)
Figure 40. Global Budesonide Revenue Share by Application (2024-2029)
Figure 41. Key Raw Materials Price Trend
Figure 42. Manufacturing Cost Structure of Budesonide
Figure 43. Manufacturing Process Analysis of Budesonide
Figure 44. Budesonide Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs